Fresenius Medical Care AG (NYSE:FMS) gapped up before the market opened on Tuesday . The stock had previously closed at $43.61, but opened at $43.73. Fresenius Medical Care AG shares last traded at $44.03, with a volume of 71,865 shares.

Several equities research analysts have commented on the company. DZ Bank AG reiterated a “neutral” rating on shares of Fresenius Medical Care AG in a research note on Thursday, August 4th. Goldman Sachs Group Inc. reiterated a “buy” rating on shares of Fresenius Medical Care AG in a research note on Tuesday, September 13th. Royal Bank Of Canada reiterated a “hold” rating on shares of Fresenius Medical Care AG in a research note on Tuesday, May 24th. Citigroup Inc. upgraded Fresenius Medical Care AG from a “neutral” rating to a “buy” rating in a research note on Tuesday, September 6th. Finally, Berenberg Bank reiterated a “buy” rating on shares of Fresenius Medical Care AG in a research note on Tuesday, August 9th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the stock. Fresenius Medical Care AG presently has a consensus rating of “Hold” and an average target price of $42.50.

The company’s 50-day moving average price is $45.27 and its 200-day moving average price is $43.75. The firm has a market cap of $26.92 billion, a PE ratio of 24.41 and a beta of 0.53.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/20/fresenius-medical-care-ag-fms-shares-gap-up-to-43-73.html

Fresenius Medical Care AG (NYSE:FMS) last announced its quarterly earnings data on Tuesday, August 2nd. The company reported $0.96 EPS for the quarter, beating the Zacks’ consensus estimate of $0.92 by $0.04. The firm earned $4.42 billion during the quarter, compared to the consensus estimate of $4.54 billion. Fresenius Medical Care AG had a net margin of 6.40% and a return on equity of 9.66%. On average, equities analysts anticipate that Fresenius Medical Care AG will post $2.01 EPS for the current fiscal year.

Large investors have recently made changes to their positions in the stock. Independent Portfolio Consultants Inc. increased its stake in shares of Fresenius Medical Care AG by 3.7% in the first quarter. Independent Portfolio Consultants Inc. now owns 6,025 shares of the company’s stock worth $266,000 after buying an additional 215 shares during the last quarter. Ngam Advisors L.P. increased its stake in shares of Fresenius Medical Care AG by 52.4% in the first quarter. Ngam Advisors L.P. now owns 22,301 shares of the company’s stock worth $983,000 after buying an additional 7,666 shares during the last quarter. Wrapmanager Inc. purchased a new stake in shares of Fresenius Medical Care AG during the first quarter worth approximately $295,000. JPMorgan Chase & Co. increased its stake in shares of Fresenius Medical Care AG by 1.5% in the first quarter. JPMorgan Chase & Co. now owns 134,551 shares of the company’s stock worth $5,930,000 after buying an additional 1,950 shares during the last quarter. Finally, Marietta Investment Partners LLC purchased a new stake in shares of Fresenius Medical Care AG during the first quarter worth approximately $620,000. Hedge funds and other institutional investors own 2.33% of the company’s stock.

About Fresenius Medical Care AG

Fresenius Medical Care AG & Co KGaA (FMC AG & CO. KGAA) is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end stage renal disease (ESRD), as well as other healthcare services. The Company operates through four segments: North America, Europe, Middle East, Africa (EMEA), Asia-Pacific and Latin America.

5 Day Chart for NYSE:FMS

Receive News & Ratings for Fresenius Medical Care AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG and related companies with MarketBeat.com's FREE daily email newsletter.